| |
 |
|
|
|
|
|
|
|
|
-
AirPurifiersDirect2U.com Adds Blueair Air Purifiers to Its Air Purifier Line-up
Bill Unyi, founder of AirPurifiersDirect2U.com, speaks about increased air purifier sales potential by adding one of the Top Brands in the industry in Blueair
Read more ...
-
JBNI Releases Atmen, an All Natural Herbal Formula for Sinus Allergies
JBNI, a recognized leader in the fields of cancer research, genetics, and proteomics, announced today the release of Atmen, an upper respiratory formula for allergies and sinus health. The release of this new formula was in response to JBNI users' demand for an upper respiratory formula for sinus allergies to complement the general herbal allergy and constant fatigue fighter Epstin.
Read more ...
-
Free Online Medical Dictionaries on the Net
The "Free Medical Dictionary" is a new website that goes into the art and science of healing (Medicine).
Read more ...
-
Dr. Don A. Bukstein joins Strategic Pulmonary Advisors
Strategic Pharmaceutical Advisors (SRxA) a leading U.S. healthcare strategic marketing consulting and education firm, proudly announces the addition of Don A. Bukstein, MD, as Vice President of Strategic Pulmonary Advisors (SPA), a SRxA affiliated company.
Read more ...
-
Influenza Antibody Spray Success: Opens New Approach to Respiratory Disease Control
Anadis Limited (ASX: ANX), a research driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced today important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.
Read more ...
-
New Paralda Eco-Friendly Air Purifier is a Back-to-School Essential for the Child with Allergies or Asthma
Alen Corporation's new green air purifier cleans indoor air unlike any other air purifier presently available to U.S. consumers. The new Paralda is made with 100% lead free components, ozone safe, and Energy Star qualified. It is the first and only lead-free air purifier ever available in the United States. Paralda's safety features and powerful indoor air cleaning abilitiy make it especially suitable for homes with pets and children.
Read more ...
-
AirPurifiersDirect2U.com Announces Financial Results and Top Selling Air Purifiers for 2nd Quarter of 2008
Bill Unyi, founder of AirPurifiersDirect2U.com, releases their 2nd Quarter Financial results along with a list of their Top Selling air purifier products for the same time period.
Read more ...
-
WellDoc and AstraZeneca Collaborate to Develop Asthma Management Solution : Collaboration will create patient-centric, mobile- and Web-based tools to help asthma sufferers
WellDoc Communications, Inc., a healthcare company that develops technology solutions to help improve chronic disease management, is partnering with AstraZeneca Pharmaceuticals LP to educate patients about the importance of their medicine in asthma control. As part of its patient support program AstraZeneca’s respiratory franchise will utilize WellDoc’s web- and mobile-based asthma solution, including virtual messenger, air quality and pollen count alerts as well as online patient support tools, allowing patients to manage their condition, consistent with the treatment plan of the patient’s physician, throughout their day and in real time.
Read more ...
-
Dynavax Receives Milestone from AstraZeneca : Novel Asthma/COPD Drug Candidate Nominated for Clinical Development
Dynavax Technologies, Inc. (NASDAQ:DVAX) today announced receipt of a $4.5 million milestone payment from its partner AstraZeneca AB for the nomination of candidate drug AZD1419 for the treatment of asthma and chronic obstructive pulmonary disease (COPD). As part of this potential $136 million development and commercialization collaboration, AstraZeneca and Dynavax have initiated Investigational New Drug (IND) enabling studies with AZD1419 and plan to begin phase 1 clinical development in 2009.
Read more ...
-
HFA Transition Provides an Opportunity to Improve AerobidĀ® Inhaler : Trudell ramps up production of AEROCOUNTĀ® Dose Indicator in preparation to supply Forest Laboratories, Inc. with commercial volumes to support their CFC to HFA transition on Flunisoli
Trudell Medical International is pleased to announce the selection of the AEROCOUNT® Dose Indicator for use with Forest’s proprietary product containing the active ingredient Flunisolide in an HFA formulation.
Read more ...
 |
|
 |
|
|
|
|
|